Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway

Imatinib (IM) resistance could have significant impact on the survival time of the CML-patients treated with IM. Previous studies have shown that the protective effects of the bone marrow stroma cells (BMSCs) on CML cells are achieved by the secretion of CXCL12. The aim of this study was to investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Hanbo, Li, Wenjun, Zhou, Yizhou, Tan, Renxiang, Yang, Yue, Zhou, You, Guo, Qinglong, Zhao, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463784/
https://www.ncbi.nlm.nih.gov/pubmed/31024831
http://dx.doi.org/10.3389/fonc.2019.00188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463784/
https://www.ncbi.nlm.nih.gov/pubmed/31024831
http://dx.doi.org/10.3389/fonc.2019.00188

Ejemplares similares